People | June 04, 2026
Dr. Saurabh Lall joins KIMS Hospitals as Chief Operating Officer
Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management
Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients
Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
Specialised clinic to offer regular device monitoring, battery assessment, rhythm evaluation, and expert cardiac electrophysiology consultation
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
At the center of the project is a new cosmetics line developed through collaboration between industry and medicine
Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials is the bioequivalent to the reference listed drug (RLD) Halaven injection of Eisai, Inc.
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
Subscribe To Our Newsletter & Stay Updated
